Research Tracker›Biomarker Atlas›Marker Pages›Ehrlichia / Ehrlichiosis panel

Ehrlichia / Ehrlichiosis panel: biomarker evidence

Ehrlichia / Ehrlichiosis panel appears in 1 entry of the OSMF biomarker atlas, covering Lyme Disease. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Lyme Disease

Where Ehrlichia / Ehrlichiosis panel is reported

Also listed as: Tick co-infection

ConditionDirectionCompared againstAssociated symptomsSource
Lyme Disease↑ elevatedUninfectedFever, leukopenia, thrombocytopeniaSwanson et al. 2022

Frequently asked questions

In which conditions is Ehrlichia / Ehrlichiosis panel altered?

In the OSMF atlas Ehrlichia / Ehrlichiosis panel is reported in Lyme Disease. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Ehrlichia / Ehrlichiosis panel?

The atlas entries for Ehrlichia / Ehrlichiosis panel do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Ehrlichia / Ehrlichiosis panel result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Ehrlichia / Ehrlichiosis panel across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/ehrlichia-ehrlichiosis-panel.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.